These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 37689059)

  • 1. Irisin reduces amyloid-β by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signaling.
    Kim E; Kim H; Jedrychowski MP; Bakiasi G; Park J; Kruskop J; Choi Y; Kwak SS; Quinti L; Kim DY; Wrann CD; Spiegelman BM; Tanzi RE; Choi SH
    Neuron; 2023 Nov; 111(22):3619-3633.e8. PubMed ID: 37689059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes.
    Yamamoto N; Ishikuro R; Tanida M; Suzuki K; Ikeda-Matsuo Y; Sobue K
    Neuroscience; 2018 Aug; 385():227-236. PubMed ID: 29932983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes.
    Mulder SD; Veerhuis R; Blankenstein MA; Nielsen HM
    Exp Neurol; 2012 Jan; 233(1):373-9. PubMed ID: 22101005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin and atorvastatin facilitates amyloid β-protein degradation in extracellular spaces by increasing neprilysin secretion from astrocytes through activation of MAPK/Erk1/2 pathways.
    Yamamoto N; Fujii Y; Kasahara R; Tanida M; Ohora K; Ono Y; Suzuki K; Sobue K
    Glia; 2016 Jun; 64(6):952-62. PubMed ID: 26875818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigallocatechin gallate induces extracellular degradation of amyloid β-protein by increasing neprilysin secretion from astrocytes through activation of ERK and PI3K pathways.
    Yamamoto N; Shibata M; Ishikuro R; Tanida M; Taniguchi Y; Ikeda-Matsuo Y; Sobue K
    Neuroscience; 2017 Oct; 362():70-78. PubMed ID: 28844000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HIAA induces neprilysin to ameliorate pathophysiology and symptoms in a mouse model for Alzheimer's disease.
    Klein C; Roussel G; Brun S; Rusu C; Patte-Mensah C; Maitre M; Mensah-Nyagan AG
    Acta Neuropathol Commun; 2018 Dec; 6(1):136. PubMed ID: 30537985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(I:C) promotes neurotoxic amyloid β accumulation through reduced degradation by decreasing neprilysin protein levels in astrocytes.
    Yamamoto N; Tokumon T; Obuchi A; Kono M; Saigo K; Tanida M; Ikeda-Matsuo Y; Sobue K
    J Neurochem; 2022 Dec; 163(6):517-530. PubMed ID: 36321194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin inhibits amyloid β-protein degradation through decrease of neprilysin expression in primary cultured astrocytes.
    Yamamoto N; Tanida M; Ono Y; Kasahara R; Fujii Y; Ohora K; Suzuki K; Sobue K
    Biochem Biophys Res Commun; 2014 Feb; 445(1):214-7. PubMed ID: 24508800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine reduces amyloid β-protein degradation by suppressing neprilysin expression in primary cultured astrocytes.
    Yamamoto N; Arima H; Naruse K; Kasahara R; Taniura H; Hirate H; Sugiura T; Suzuki K; Sobue K
    Neurosci Lett; 2013 Jun; 545():54-8. PubMed ID: 23624023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.
    Liu CC; Hu J; Zhao N; Wang J; Wang N; Cirrito JR; Kanekiyo T; Holtzman DM; Bu G
    J Neurosci; 2017 Apr; 37(15):4023-4031. PubMed ID: 28275161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.
    Meilandt WJ; Cisse M; Ho K; Wu T; Esposito LA; Scearce-Levie K; Cheng IH; Yu GQ; Mucke L
    J Neurosci; 2009 Feb; 29(7):1977-86. PubMed ID: 19228952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer's disease.
    Rofo F; Metzendorf NG; Saubi C; Suominen L; Godec A; Sehlin D; Syvänen S; Hultqvist G
    Alzheimers Res Ther; 2022 Dec; 14(1):180. PubMed ID: 36471433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripherally expressed neprilysin reduces brain amyloid burden: a novel approach for treating Alzheimer's disease.
    Guan H; Liu Y; Daily A; Police S; Kim MH; Oddo S; LaFerla FM; Pauly JR; Murphy MP; Hersh LB
    J Neurosci Res; 2009 May; 87(6):1462-73. PubMed ID: 19021293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of exercise-hormone irisin in Alzheimer's disease.
    Kim E; Tanzi RE; Choi SH
    Neural Regen Res; 2025 Jun; 20(6):1555-1564. PubMed ID: 38993140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating AhR alleviates cognitive deficits of Alzheimer's disease model mice by upregulating endogenous Aβ catabolic enzyme Neprilysin.
    Qian C; Yang C; Lu M; Bao J; Shen H; Deng B; Li S; Li W; Zhang M; Cao C
    Theranostics; 2021; 11(18):8797-8812. PubMed ID: 34522212
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
    Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
    Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice.
    Devi L; Ohno M
    Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Role of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytic Aβ Clearance.
    Zhang H; Chen W; Tan Z; Zhang L; Dong Z; Cui W; Zhao K; Wang H; Jing H; Cao R; Kim C; Safar JG; Xiong WC; Mei L
    J Neurosci; 2020 Jul; 40(28):5347-5361. PubMed ID: 32457076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological ablation of astrocytes reduces Aβ degradation and synaptic connectivity in an ex vivo model of Alzheimer's disease.
    Davis N; Mota BC; Stead L; Palmer EOC; Lombardero L; Rodríguez-Puertas R; de Paola V; Barnes SJ; Sastre M
    J Neuroinflammation; 2021 Mar; 18(1):73. PubMed ID: 33731156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.